Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Misinformation Contributing To Slower Biosimilar Uptake, Execs Claim
‘All Stakeholders Responsible’ For Change
Jul 23 2020
•
By
Dean Rudge
Misinformation is one of many barriers to robust and competitive market for biosimilars • Source: Shutterstock
More from Biosimilars
More from Products